tradingkey.logo
tradingkey.logo
Search

Procept Biorobotics Corp

PRCT
Add to Watchlist
21.765USD
-1.705-7.26%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.22BMarket Cap
LossP/E TTM

TradingKey Stock Score of Procept Biorobotics Corp

Currency: USD Updated: 2026-07-01

Key Insights

Procept Biorobotics Corp's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 49 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 32.54.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Procept Biorobotics Corp's Score

Industry at a Glance

Industry Ranking
49 / 204
Overall Ranking
146 / 4564
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Procept Biorobotics Corp Highlights

StrengthsRisks
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 126.19% year-on-year.
Overvalued
The company’s latest PE is -12.82, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.01M shares, decreasing 1.54% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 1.07M shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
32.538
Target Price
+44.10%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Procept Biorobotics Corp?

The TradingKey Stock Score provides a comprehensive assessment of Procept Biorobotics Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Procept Biorobotics Corp’s performance and outlook.

How do we generate the financial health score of Procept Biorobotics Corp?

To generate the financial health score of Procept Biorobotics Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Procept Biorobotics Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Procept Biorobotics Corp.

How do we generate the company valuation score of Procept Biorobotics Corp?

To generate the company valuation score of Procept Biorobotics Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Procept Biorobotics Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Procept Biorobotics Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Procept Biorobotics Corp.

How do we generate the earnings forecast score of Procept Biorobotics Corp?

To calculate the earnings forecast score of Procept Biorobotics Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Procept Biorobotics Corp’s future.

How do we generate the price momentum score of Procept Biorobotics Corp?

When generating the price momentum score for Procept Biorobotics Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Procept Biorobotics Corp’s prices. A higher score indicates a more stable short-term price trend for Procept Biorobotics Corp.

How do we generate the institutional confidence score of Procept Biorobotics Corp?

To generate the institutional confidence score of Procept Biorobotics Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Procept Biorobotics Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Procept Biorobotics Corp.

How do we generate the risk management score of Procept Biorobotics Corp?

To assess the risk management score of Procept Biorobotics Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Procept Biorobotics Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Procept Biorobotics Corp.